<DOC>
	<DOCNO>NCT00359307</DOCNO>
	<brief_summary>The purpose study identify gene associate certain risk factor atherosclerosis ( harden artery ) consequence , development coronary artery disease , heart attack , blood vessel disease stroke . People enrol Framingham Heart Study Framingham , Massachusetts , eligible participate study . They undergo medical history , include review medical record family history ; evaluation memory mood ; breathe test electrocardiogram ( EKG ) ; blood urine test , include blood sample collection DNA ( genetic ) testing ; evaluation gait ( walk ) , balance hand grip strength ; hear test . They also fill questionnaire eat habit general health . Any patient may suffer stroke study examine hospitalization 3 , 6 , 12 , 24 month stroke . This examination include neurological evaluation , assessment ability perform daily live task , possibly , magnetic resonance imaging ( MRI ) brain , test use strong magnetic field radio wave produce picture brain .</brief_summary>
	<brief_title>Genetic Factors Atherosclerosis</brief_title>
	<detailed_description>We study relationship genetic variant human immune system atherosclerosis collaboration Framingham Heart Study . Since atherosclerosis disease chronic inflammation arterial vessel wall , genetic variant molecules responsible migration leukocytes likely explain genetic diversity rate heart disease stroke . Therefore conduct molecular epidemiology study genetics atherosclerosis use material clinical data already collect Framingham Heart Study . The Heart Study prospective epidemiological study natural history heart disease stroke involved individual reside Framingham , Massachusetts since 1950s . We compare risks individual particular genotype develop atherosclerosis sequela , coronary artery disease , heart attack , peripheral vascular disease , stroke . If correlation genotype risk atherosclerosis find , facilitate new treatment disease base interference particular component human immune system .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Between age 18 65 year inclusive 2 . Access primary medical care provider outside NIH 3 . Able give inform consent 4 . Willingness history physical examination annually EXCLUSION CRITERIA : 1 . History malignancy autoimmune disease rheumatoid arthritis , vasculitis , pyoderma gangrenosum 2 . Use systemic corticosteroid within past month 3 . Use local corticosteroid propose blister site within past month 4 . Evidence current acute infection 5 . Personal family history keloid formation 6 . Use investigative drug within past month 7 . History skin disease within past one year ( e.g . psoriasis , atopic dermatitis ) 8 . History diabetes</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 21, 2013</verification_date>
	<keyword>Genetic</keyword>
	<keyword>Longitudinal</keyword>
	<keyword>Prospective</keyword>
	<keyword>Epidemiology</keyword>
	<keyword>Heart Attack</keyword>
</DOC>